The NCCNN Education Advisory Group is committed to working collaboratively to support colorectal cancer nurses, raising their voices and ensuring their essential contributions are recognised. Through ...

This session will be led by Claire Coughlan, Clinical Lead at Bowel Cancer UK and Nurse Consultant in colorectal cancer at Lewisham and Greenwich NHS Trust. It'll provide an overview of colorectal ...

Mr Rob Jones is a consultant surgeon based in Liverpool and the UK research lead for advanced and metastatic colorectal cancer.He's funded by Bowel Cancer UK, the Royal College of Surgeons of England ...

Nearly a third of bowel cancer patients experience a delay to their diagnosis that could have been avoided, according to a new study published in Cancer Epidemiology. The study looked at national ...

The number of people in England waiting longer than six weeks for tests that can help to diagnose bowel cancer has increased by nearly eight-fold compared to pre-pandemic levels, according to figures ...

A new report out today shows bowel cancer costs the UK economy more than £1.7 billion (€1.9 billion) a year. The report, commissioned by Digestive Cancers Europe, calculated the cost of diagnosis and ...

Charlotte's husband, Roger, was diagnosed with bowel cancer in 2017. Here Charlotte talks about supporting her partner through diagnosis, treatment and beyond, as well as talking to children about ...

Bacteria commonly found in our guts could contribute to the development of bowel cancer, according to a new study published in Nature today. The study, led by scientists in the UK, the USA and the ...

A new study has found that increasing the sensitivity of the faecal immunochemical test (FIT) can help to identify more cases of bowel cancer, advanced polyps (non-cancerous growths) and Inflammatory ...

Our new survey revealed that nearly four in ten (38%) people can't name a single symptom of bowel cancer. The disease is the UK's second biggest cancer killer, but nearly three quarters of people (71% ...

Our figures show the number of bowel cancer screening invitations not sent out in England have surpassed the million mark since lockdown began in March. In addition to this, around 8,500 people who ...

A new bowel cancer drug, which can double progression-free survival time for some people with advanced bowel cancer, has been approved by the Scottish Medicines Consortium (SMC) for patients in ...